Full Press Release Details
Ms. Bruno brings over 25 years of experience in the life sciences industry, spanning biotechnology, medical device, and pharmaceutical drug development. She began her career at the bench in an analytical laboratory supporting the characterization of investigational products through pharmacokinetic profiling and pharmacodynamic endpoint assessment across clinical and non-clinical studies. Building on her scientific foundation, she transitioned into strategic Quality leadership, partnering with emerging and growth-stage biopharmaceutical companies to design, implement, and mature scalable, inspection-ready Quality frameworks aligned with global regulatory standards. Prior to joining Immuneering in February 2026, Ms. Bruno held Quality leadership roles at Entasis Therapeutics , Spyre Therapeutics , and Geron Corporation . Ms. Bruno holds a Graduate Certificate in Regulatory Affairs from Northeastern University, an M.S. in Biotechnology from Worcester State University, and a B.S. in Biology from Framingham State University.